RESUMEN
BACKGROUND: Previous reports have suggested that despite their dramatic presentation, patients with fulminant myocarditis (FM) might have better outcome than those with acute nonfulminant myocarditis (NFM). In this retrospective study, we report outcome and changes in left ventricular ejection fraction (LVEF) in a large cohort of patients with FM compared with patients with NFM. METHODS: The study population consists of 187 consecutive patients admitted between May 2001 and November 2016 with a diagnosis of acute myocarditis (onset of symptoms <1 month) of whom 55 required inotropes and/or mechanical circulatory support (FM) and the remaining 132 were hemodynamically stable (NFM). We also performed a subanalysis in 130 adult patients with acute viral myocarditis and viral prodrome within 2 weeks from the onset, which includes 34 with FM and 96 with NFM. Patients with giant-cell myocarditis, eosinophilic myocarditis, or cardiac sarcoidosis and those <15 years of age were excluded from the subanalysis. RESULTS: In the whole population (n=187), the rate of in-hospital death or heart transplantation was 25.5% versus 0% in FM versus NFM, respectively (P<0.0001). Long-term heart transplantation-free survival at 9 years was lower in FM than NFM (64.5% versus 100%, log-rank P<0.0001). Despite greater improvement in LVEF during hospitalization in FM versus NFM forms (median, 32% [interquartile range, 20%-40%] versus 3% [0%-10%], respectively; P<0.0001), the proportion of patients with LVEF <55% at last follow-up was higher in FM versus NFM (29% versus 9%; relative risk, 3.32; 95% confidence interval, 1.45-7.64, P=0.003). Similar results for survival and changes in LVEF in FM versus NFM were observed in the subgroup (n=130) with viral myocarditis. None of the patients with NFM and LVEF ≥55% at discharge had a significant decrease in LVEF at follow-up. CONCLUSIONS: Patients with FM have an increased mortality and need for heart transplantation compared with those with NFM. From a functional viewpoint, patients with FM have a more severely impaired LVEF at admission that, despite steep improvement during hospitalization, remains lower than that in patients with NFM at long-term follow-up. These findings also hold true when only the viral forms are considered and are different from previous studies showing better prognosis in FM.
Asunto(s)
Miocarditis/diagnóstico , Función Ventricular Izquierda/fisiología , Enfermedad Aguda , Adolescente , Adulto , Ecocardiografía , Femenino , Estudios de Seguimiento , Corazón/diagnóstico por imagen , Trasplante de Corazón , Corazón Auxiliar , Hemodinámica , Mortalidad Hospitalaria , Humanos , Inmunosupresores/uso terapéutico , Estimación de Kaplan-Meier , Imagen por Resonancia Cinemagnética , Masculino , Miocarditis/mortalidad , Miocarditis/terapia , Miocardio/patología , Adulto JovenRESUMEN
Spontaneous hepatic rupture (SHR) during pregnancy is a rare but well known complication and it usually occurs alongside eclampsia or HELLP syndrome. SHR in uncomplicated pregnancy is extremely rare and can be associated to different undiagnosed pathological conditions. We report the case of a nulliparous woman, 27 weeks pregnant, with a peliosis hepatis, previously unknown, who was admitted to our unit due to SHR and massive hemoperitoneum. The conception was obtained by embryo transfer after multiple attempts of hormone-supported cycles using estrogens and progesterone. After emergency laparotomy the patient was submitted to deliver of the dead foetus and damage control of the hepatic bleeding source. At relaparotomy a right posterior sectionectomy (segments VI and VII) and segmentectomy of segment V were performed. The patient was discharged in good physical conditions after 18 days from admission. If hepatic rupture is suspected in a pregnant patient a collaborative multidisciplinary approach is mandatory. The cornerstones of medical and surgical management are highlighted. At the best of our knowledge this is the first case of SHR in a pregnant woman with peliosis hepatis. A possible correlation of an increased risk for SHR in a pregnant patient who was submitted to several attempts for embryo transfer is discussed. The relevant scientific literature of the possible causative role of the estrogen therapy in inducing politic liver damage is also reviewed.
Asunto(s)
Hígado/patología , Peliosis Hepática/complicaciones , Complicaciones del Embarazo , Técnicas Reproductivas Asistidas , Biopsia , Femenino , Muerte Fetal/etiología , Hemoperitoneo/etiología , Hepatectomía , Humanos , Persona de Mediana Edad , Peliosis Hepática/diagnóstico , Embarazo , Complicaciones del Embarazo/diagnóstico , Rotura Espontánea , Tomografía Computarizada por Rayos X , Resultado del TratamientoAsunto(s)
Adenocarcinoma/diagnóstico , Neoplasias Encefálicas/secundario , Eosinofilia/diagnóstico , Neoplasias Pulmonares/diagnóstico , Miocarditis/diagnóstico , Síndromes Paraneoplásicos/diagnóstico , Adenocarcinoma/tratamiento farmacológico , Adenocarcinoma/etiología , Biopsia , Neoplasias Encefálicas/tratamiento farmacológico , Cardiomegalia/diagnóstico por imagen , Cardiomegalia/etiología , Diagnóstico Diferencial , Disnea/etiología , Ecocardiografía , Electrocardiografía , Femenino , Humanos , Neoplasias Pulmonares/tratamiento farmacológico , Neoplasias Pulmonares/etiología , Persona de Mediana Edad , Miocardio/patología , Síndromes Paraneoplásicos/etiología , Derrame Pericárdico/diagnóstico por imagen , Derrame Pericárdico/etiología , Derrame Pleural/diagnóstico por imagen , Derrame Pleural/etiología , Derrame Pleural/patología , Radiografía , Insuficiencia Respiratoria/etiología , Choque Cardiogénico/etiología , Fumar/efectos adversosRESUMEN
The clinical presentation of pheochromocytoma is variable and many biochemical and imaging methods have been suggested to improve the diagnostic accuracy of what has been termed "the great masquerader". This case-report is of a middle-aged woman with a non-specific clinical presentation suggesting acute coronary syndrome or subacute myocarditis. Cardiovascular magnetic resonance (CMR) at presentation showed myocardial edema and intramyocardial late gadolinium enhancement (LGE). An adrenal mass was seen, which was confirmed as pheochromocytoma and surgically removed. Our case shows evidence for acute adrenergic myocarditis, with resolution of both the edema and the LGE after surgical excision.
Asunto(s)
Neoplasias de las Glándulas Suprarrenales/complicaciones , Catecolaminas/orina , Miocarditis/etiología , Feocromocitoma/complicaciones , Disfunción Ventricular Izquierda/etiología , Enfermedad Aguda , Neoplasias de las Glándulas Suprarrenales/cirugía , Neoplasias de las Glándulas Suprarrenales/orina , Adrenalectomía , Medios de Contraste , Edema Cardíaco/etiología , Femenino , Gadolinio , Humanos , Imagen por Resonancia Magnética , Persona de Mediana Edad , Miocarditis/orina , Feocromocitoma/cirugía , Feocromocitoma/orina , Resultado del Tratamiento , Disfunción Ventricular Izquierda/orinaRESUMEN
In patients with left ventricular assist device (LVAD), a minority of post-operative ventricular tachycardias (VTs) is caused by contact between the inflow cannula and the endocardium. Currently, electrophysiologic characteristics and pathologic features of this condition are lacking. We report on a case of a successfully ablated mechanical VT. After VT recurrence, heart transplantation took place. Pathologic observations were consistent with direct tissue injury and inflammation, eventually contributing to persisting arrhythmias. Radiofrequency catheter ablation can be a safe and effective option to treat arrhythmias caused by inflow cannula interference in the short term, although a high recurrence rate is expected.
RESUMEN
Diagnosis of benign and purely localized malignant adrenocortical lesions is still a complex issue. Moreover, histology-based diagnosis may suffer of a moment of subjectivity due to inter- and intra-individual variations. The aim of the present study was to assess, by computerized morphometry, the morphological features in benign and malignant adrenocortical neoplasms. Eleven adrenocortical adenomas (ACA) were compared with 18 adrenocortical cancers (ACC). All specimens were stained with H&E, cellular proliferation marker Ki-67 and reticulin. We generated a morphometric model based on the analysis of volume fractions occupied by Ki-67 positive and negative cells (nuclei and cytoplasm), vascular and inflammatory compartment; we also analyzed the surface fraction occupied by reticulin. We compared the quantitative data of Ki-67 obtained by morphometry with the quantification resulting from pathologist's visual reading. The volume fraction of Ki-67 positive cells in ACCs was higher than in ACAs. The volume fraction of nuclei in unit volume and the nuclear/cytoplasmic ratio in both Ki-67 negative cells and Ki-67 positive cells were prominent in ACCs. The surface fraction of reticulin was considerably lower in ACCs. Our computerized morphometric model is simple, reproducible and can be used by the pathologist in the histological workup of adrenocortical tumors to achieve precise and reader-independent quantification of several morphological characteristics of adrenocortical tumors.
Asunto(s)
Neoplasias de la Corteza Suprarrenal/química , Neoplasias de la Corteza Suprarrenal/patología , Adenoma Corticosuprarrenal/química , Adenoma Corticosuprarrenal/patología , Carcinoma Corticosuprarrenal/química , Carcinoma Corticosuprarrenal/patología , Biomarcadores de Tumor/análisis , Interpretación de Imagen Asistida por Computador , Inmunohistoquímica , Adulto , Anciano , Biopsia , Proliferación Celular , Femenino , Humanos , Antígeno Ki-67/análisis , Masculino , Persona de Mediana Edad , Variaciones Dependientes del Observador , Valor Predictivo de las Pruebas , Reproducibilidad de los Resultados , Reticulina/análisis , Estudios Retrospectivos , Carga TumoralAsunto(s)
Paro Cardíaco/diagnóstico , Infarto del Miocardio/diagnóstico , Arteritis de Takayasu/complicaciones , Aorta Torácica/diagnóstico por imagen , Aorta Torácica/patología , Reanimación Cardiopulmonar , Circulación Colateral , Dilatación Patológica/diagnóstico por imagen , Electrocardiografía , Femenino , Hematoma/diagnóstico por imagen , Hematoma/patología , Humanos , Hiperplasia/diagnóstico por imagen , Hiperplasia/patología , Imagen por Resonancia Magnética , Persona de Mediana Edad , Infarto del Miocardio/diagnóstico por imagen , Infarto del Miocardio/patología , Tomografía Computarizada por Rayos XRESUMEN
: A 31-year-old man presenting with cardiogenic shock and left ventricular ejection fraction of 10% received the diagnosis of giant cell myocarditis by endomyocardial biopsy. The patient was successfully treated with high-dose inotropes, intra-aortic balloon pump and venoarterial extracorporeal membrane oxygenation for 21 days associated with combined immunosuppression (thymoglobulin, steroids, cyclosporine). Immunosuppression including thymoglobulin is the regimen associated with the highest probability of recovery in case of giant cell myocarditis. Immunosuppression needs time to be effective; thus, hemodynamic support must be guaranteed. In the present case, we observed that full recovery can be obtained up to 21 days of support with extracorporeal membrane oxygenation and adequate immunosuppression.
Asunto(s)
Suero Antilinfocítico/administración & dosificación , Oxigenación por Membrana Extracorpórea , Células Gigantes/efectos de los fármacos , Inmunosupresores/administración & dosificación , Miocarditis/terapia , Choque Cardiogénico/terapia , Adulto , Biopsia , Cardiotónicos/uso terapéutico , Terapia Combinada , Células Gigantes/inmunología , Células Gigantes/patología , Humanos , Contrapulsador Intraaórtico , Imagen por Resonancia Magnética , Masculino , Miocarditis/diagnóstico , Miocarditis/inmunología , Miocarditis/fisiopatología , Recuperación de la Función , Choque Cardiogénico/diagnóstico , Choque Cardiogénico/inmunología , Factores de Tiempo , Resultado del TratamientoRESUMEN
: Necrotizing eosinophilic myocarditis (NEM) is a life-threatening condition that needs rapid diagnosis by endomyocardial biopsy and hemodynamic support usually by mechanical circulatory systems. We present the case of a 25-year-old Caucasian man who developed a refractory cardiogenic shock due to a NEM that was supported with a peripheral veno-arterial extracorporeal membrane oxygenation associated with intravenous steroids and recovered after 2 weeks. Further instrumental investigations lead to the final diagnosis of NEM as first presentation of eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome), remarking the importance of identifying the systemic disorder that usually triggers the eosinophilic damage of the myocardium.
Asunto(s)
Síndrome de Churg-Strauss/complicaciones , Granulomatosis con Poliangitis/complicaciones , Miocarditis/etiología , Choque Cardiogénico/etiología , Administración Intravenosa , Adulto , Biopsia , Síndrome de Churg-Strauss/diagnóstico , Síndrome de Churg-Strauss/terapia , Oxigenación por Membrana Extracorpórea , Granulomatosis con Poliangitis/diagnóstico , Granulomatosis con Poliangitis/terapia , Humanos , Inmunosupresores/administración & dosificación , Imagen por Resonancia Magnética , Masculino , Miocarditis/diagnóstico , Miocarditis/terapia , Miocardio/patología , Necrosis , Choque Cardiogénico/diagnóstico , Choque Cardiogénico/terapia , Esteroides/administración & dosificación , Factores de Tiempo , Resultado del TratamientoRESUMEN
We report the histopathologic correlates of late gadolinium enhancement (LGE) at cardiac magnetic resonance (CMR) in a patient with heart transplant who died for graft failure a few months after the scan. Extensive late enhancement was present at CMR, and it correlated with extensive fibrosis at histology. To our knowledge, this is the first time the findings on contrast enhancement CMR are compared to the histology of the whole heart in a heart transplantation patient, and the correspondence between LGE and fibrosis, demonstrated in other cardiac pathologies, is confirmed also in this particular setting.
Asunto(s)
Medios de Contraste , Gadolinio DTPA , Rechazo de Injerto/patología , Cardiopatías/patología , Trasplante de Corazón/efectos adversos , Imagen por Resonancia Magnética , Miocardio/patología , Adulto , Autopsia , Causas de Muerte , Resultado Fatal , Fibrosis , Rechazo de Injerto/etiología , Rechazo de Injerto/terapia , Paro Cardíaco/etiología , Paro Cardíaco/patología , Cardiopatías/etiología , Cardiopatías/terapia , Insuficiencia Cardíaca/etiología , Insuficiencia Cardíaca/patología , Humanos , Masculino , Valor Predictivo de las Pruebas , Resultado del TratamientoRESUMEN
Endomyocardial biopsy (EMB) is the gold standard for the diagnosis of myocarditis. Patients with clinical presentation consistent with myocarditis and acute heart failure should undergo EMB, in particular to exclude giant-cell myocarditis or necrotizing eosinophilic myocarditis that are life-threatening conditions. The indication for EMB is debatable in case of suspected myocarditis with infarct-like presentation and preserved left ventricular ejection fraction. In fact, in this group of patients the prognosis is fairly good, and the clinical advantage to reach a histological diagnosis by means of an invasive procedure with potential complications such as EMB is limited. In this article we discuss the indication for EMB in the light of current guidelines based on existing consensus documents.
Asunto(s)
Biopsia/métodos , Miocarditis/diagnóstico , Miocardio/patología , Insuficiencia Cardíaca/diagnóstico , Insuficiencia Cardíaca/fisiopatología , Humanos , Miocarditis/fisiopatología , Selección de Paciente , Pronóstico , Función Ventricular IzquierdaRESUMEN
We report the description of a cardiac mass occupying almost the entire right atrium in a young man who developed paroxysmal supraventricular tachycardia during endovascular treatment of intracranial arteriovenous fistulas. The mass was detected at echocardiographic examination, its tissue characteristics were defined with cardiac magnetic resonance and it was successfully surgically removed. The histopathological findings were consistent with a mixed type cavernous-capillary hemangioma of the heart. The intriguing co-existence of cardiac hemangioma and cerebral arteriovenous fistulas, to the best of our knowledge, has not been previously reported in English Literature.
Asunto(s)
Fístula Arteriovenosa/cirugía , Hemangioma/etiología , Taquicardia Supraventricular/etiología , Procedimientos Endovasculares/efectos adversos , Procedimientos Endovasculares/métodos , Atrios Cardíacos/diagnóstico por imagen , Atrios Cardíacos/patología , Hemangioma/diagnóstico por imagen , Humanos , Masculino , Persona de Mediana Edad , Taquicardia Supraventricular/diagnóstico por imagen , UltrasonografíaRESUMEN
Churg-Strauss syndrome, recently renamed eosinophilic granulomatosis with polyangiitis (EGPA), is a rare form of systemic vasculitis, characterized by disseminated necrotizing vasculitis with extravascular granulomas occurring among patients with asthma and tissue eosinophilia. EGPA is classified as a small and medium-sized vessel vasculitis associated with antineutrophil cytoplasmic antibodies (ANCA) and the hypereosinophilic syndrome. Typical clinical features include asthma, sinusitis, transient pulmonary infiltrates and neuropathy. Blood eosinophils are often >1500/µl or more than 10% on the differential leukocyte count. Blood eosinophils should always be tested in unexplained cardiac disorders, and may normalize even after low doses of corticosteroids. ANCA are positive in 40-60% of cases, mainly anti-myeloperoxidase. Heart involvement occurs in approximately 15-60% of EGPA patients, especially those who are ANCA negative. Any cardiac structure can be involved, and patients present with myocarditis, heart failure, pericarditis, arrhythmia, coronary arteritis, valvulopathy, intracavitary cardiac thrombosis. Although cardiovascular involvement is usually an early manifestation, it can also occur later in the course of the disease. A significant proportion of patients with cardiac involvement is asymptomatic. In the absence of symptoms and major ECG abnormalities, cardiac involvement may be detected in nearly 40% of the patients. All patients with EGPA should be studied not only with a detailed history of cardiac symptoms and ECG, but also with echocardiography; if abnormalities are detected, a cardiac magnetic resonance study should be performed. Coronary angiography and endomyocardial biopsy should be reserved to selected cases. Heart involvement carries a poor prognosis and causes 50% of the deaths of these patients. It is often insidious and underestimated. Optimal therapy is therefore important and based on high-dose corticosteroids plus immunosuppressive agents, particularly cyclophosphamide in case of myocardial inflammation. Thus, early diagnosis of cardiac involvement and subsequent therapy may prevent progression of cardiac disease. At present, the role of troponin and brain natriuretic peptide in monitoring and therapy remains unclear. Orthotopic heart transplantation is feasible in case of severe disease, even if the experience is limited in -EGPA, and optimal post-transplantation immunosuppressive strategy has yet to be defined.
Asunto(s)
Síndrome de Churg-Strauss/complicaciones , Cardiopatías/etiología , Anticuerpos Anticitoplasma de Neutrófilos/inmunología , Síndrome de Churg-Strauss/tratamiento farmacológico , Síndrome de Churg-Strauss/fisiopatología , Progresión de la Enfermedad , Glucocorticoides/uso terapéutico , Cardiopatías/fisiopatología , Cardiopatías/terapia , Trasplante de Corazón/métodos , Humanos , Inmunosupresores/uso terapéutico , Pronóstico , Índice de Severidad de la EnfermedadRESUMEN
Pheochromocytoma is a tumor arising from neuroectodermal chromaffin tissues in the adrenal gland or extra-adrenal paraganglia (paragangliomas). The prevalence of the tumor is 0.1%-0.6% in the hypertensive population, of which 10%-20% are malignant. Pheochromocytoma produces, stores, and secretes catecholamines, as well as leads to hypertensive crisis, arrhythmia, angina, and acute myocardial infarction without coronary artery diseases. We report a case of acute coronary syndrome (ACS) with a final diagnosis of multiple endocrine neoplasia with pheochromocytoma and medullary thyroid carcinoma (MTC).
RESUMEN
Myocardial infarction is usually induced in small animals by means of invasive procedures: the aim of this study was to cause heart necrosis lesions by non-invasive means. We injected rabbits with isoproterenol (3 mg/kg, i.p.) and vasopressin (0.3 mg/kg/5 min, i.v.) alone and in combination, and studied their effects on myocardial histology, electrocardiographic profiles, the appearance of the plasma cardiac necrosis marker c-troponin I (c-TPN I), hemodynamic parameters (blood pressure, heart rate), the coagulative process partial throboplastine time (PTT), and plasma nitric oxide (NO) levels. In the rabbits treated with vasopressin alone, the ischemic damage was associated with a decrease in NO values, and the appearance of electrocardiographic T-wave inversion and low plasma c-TPN I levels, whereas the animals treated with isoproterenol alone had necrotic bands in the myocardium, plasma c-TPN I, and electrocardiographic modifications (ST-segment changes and T-wave inversion). Combined treatment increased myocardial alterations such as contraction band necrosis, induced the appearance of specific hypoxic lesions such as areas of coagulative necrosis and leukocyte infiltration, and led to higher plasma c-TPN I levels and altered ECG profiles. Both drugs favored a decrease in plasma NO values and further alterations in hemodynamic parameters, such as higher blood pressure and greater procoagulant activity. The myocardial necrosis and modified cardiovascular parameters were attributed to calcium activated processes and the decrease in NO levels. As this model of myocardial damage involves the use of drugs that facilitate the opening of L-calcium channels, we also investigated their effects on cardiovascular parameters and heart histology after pretreatment with the calcium antagonist verapamil; this drug protected against the appearance of histological myocardial lesions, electrocardiographic alterations and high plasma c-TPN I levels, and prevented the hemodynamic and procoagulation changes, but did not affect the decrease in plasma NO values. The protective effects were attributed to the drug's calcium antagonist activity. In conclusion, the injection of isoproterenol and vasopressin induces a myocardial infarction non-invasively and seems to be suitable for studying early myocardial ischemic lesions and the effects of drugs interfering with myocardial damage and its related phenomena.
Asunto(s)
Bloqueadores de los Canales de Calcio/uso terapéutico , Modelos Animales de Enfermedad , Infarto del Miocardio/inducido químicamente , Infarto del Miocardio/prevención & control , Verapamilo/uso terapéutico , Animales , Presión Sanguínea/efectos de los fármacos , Electrocardiografía , Frecuencia Cardíaca/efectos de los fármacos , Isoproterenol , Masculino , Infarto del Miocardio/patología , Miocardio/patología , Óxido Nítrico/sangre , Tiempo de Tromboplastina Parcial , Conejos , Simpatomiméticos , Troponina I/sangre , Vasoconstrictores/administración & dosificación , Vasoconstrictores/efectos adversos , VasopresinasRESUMEN
Myocardial infarction is usually induced in small animals by means of invasive techniques based on mechanical coronary obstruction. As it has been reported that isoproterenol can cause ischemic myocardial alterations, lipid peroxide generation and procoagulant activity, we administered it to rabbits in order to induce a non-invasive myocardial infarction associated with above mentioned cardiovascular risk factors. Considerable ischemic alterations were observed in the animals treated with isoproterenol, including areas of myocardial necrosis, contraction band necrosis, increased plasma levels of cardiac necrosis markers (c-troponin I and myoglobin), and electrocardiographic modifications (ST segment changes and T wave inversion). The myocardial infarction was attributed to the inotropic activity of isoproterenol leading to intracellular calcium overload. The cardiac necrosis phenomena appear to be associated with isoproterenol-induced lipid peroxide generation (as shown by the decrease in plasma Vitamin E levels) and increased procoagulant activity (a shortened PTT). As this model of myocardial damage is based on the use of beta-stimulatory isoproterenol, the beta-blockers propranolol and labetalol were administered to isoproterenol-treated animals. Pretreatment with propranolol or labetalol counteracted the appearance of the myocardial histological alterations and the associated ECG and biochemical lesions. This protective activity was attributed to the beta-blockade. The results of this study demonstrate that myocardial infarction can be induced chemically and non-invasively in small laboratory animals. The procedure is proposed for the study of early ischemic myocardial lesions and the screening of drugs (such as beta-blockers) that can prevent myocardial necrosis damage and the associated risk factors.
Asunto(s)
Antagonistas Adrenérgicos beta/uso terapéutico , Labetalol/uso terapéutico , Infarto del Miocardio/prevención & control , Propranolol/uso terapéutico , Animales , Electrocardiografía , Isoproterenol , Peróxidos Lipídicos/metabolismo , Masculino , Infarto del Miocardio/inducido químicamente , Miocardio/patología , Tiempo de Tromboplastina Parcial , Conejos , Vitamina E/sangreRESUMEN
A 32-year-old male was admitted to our intensive care unit for low cardiac output syndrome. Echocardiography was suggestive of extensive hypokinesia and the ejection fraction was 0.22. Serological tests, including anti-HIV antibodies (ELISA), were negative. The patient was intubated and an intra-aortic balloon pump was inserted. Twenty-four hours after admission a paracorporeal left ventricular assist device (LVAD-MEDOS) was implanted. The left ventricular function showed progressive improvement with normalization of the ejection fraction on day 19. The device was removed on day 20. Before discharge, the patient admitted that he had had unprotected sex with numerous male acquaintances; anti-HIV testing turned positive. The final diagnosis was fulminant myocarditis during HIV seroconversion.
Asunto(s)
Seropositividad para VIH/diagnóstico , Seropositividad para VIH/terapia , Miocarditis/diagnóstico , Miocarditis/cirugía , Adulto , Gasto Cardíaco Bajo/diagnóstico , Gasto Cardíaco Bajo/fisiopatología , Gasto Cardíaco Bajo/cirugía , Angiografía Coronaria , Ecocardiografía , Seropositividad para VIH/fisiopatología , Corazón Auxiliar , Humanos , Contrapulsador Intraaórtico , Masculino , Miocarditis/fisiopatología , Volumen Sistólico/fisiología , Disfunción Ventricular Izquierda/diagnóstico , Disfunción Ventricular Izquierda/fisiopatología , Disfunción Ventricular Izquierda/cirugíaRESUMEN
OBJECTIVE: To describe, by computerized morphometry, the degree and the type of steatosis in liver transplants that developed primary nonfunction and to compare the results with the quantification by pathologist. STUDY DESIGN: Twelve patients who developed primary nonfunction after liver transplantation were matched with 23 transplanted patients with a regular postoperative clinical course. Morphology of the liver biopsy included many stereological parameters; all cases were evaluated by an operator blinded to the diagnosis and to the clinical history. The assessment of steatosis by morphometry was compared with the pathologist's evaluation. Moreover, to assess the reproducibility of the morphometric model, another operator applied the morphometric model in a blinded fashion to a randomly selected sample of cases. RESULTS: The percentage of hepatocytes with microsteatosis and the ratio of macro/microsteatosis were higher in primary nonfunction. The pathologist's evaluation of steatosis showed a marked overestimation when compared to morphometry. Lastly, the comparison between the results of 2 blinded operators of morphometric analysis showed a high reproducibility with a low interobserver variability. CONCLUSION: Our quantitative estimation of the degree and the quality of steatosis avoids interobserver interpretations. Moreover, our analysis shows that the quantification of steatosis in liver transplantation by the current assessment must be reviewed in order to reevaluate the real impact of steatosis.
Asunto(s)
Hígado Graso/patología , Hepatocitos/patología , Procesamiento de Imagen Asistido por Computador/métodos , Trasplante de Hígado/efectos adversos , Biopsia , Hígado Graso/diagnóstico , Femenino , Humanos , Hígado/patología , Masculino , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Donantes de TejidosRESUMEN
The role of the right ventricle has often been underestimated in heart failure. It has been thought that the right cavity has a less prominent impact on symptoms, therapeutic approach, and prognosis. Right ventricular dysfunction is a complex issue and its diagnosis has acquired a relevant role, in particular with the improvement of new therapeutic options such as ventricular assist devices. The complex geometry of the right ventricle and its interaction with the left ventricle are still a matter of debate, leaving several open questions about the best therapeutic approach to manage right ventricular dysfunction. Echocardiography remains the first-line imaging technique, but an integrated multimodality evaluation with clinical, biochemical and hemodynamic parameters, and cardiovascular magnetic resonance imaging can provide a more comprehensive way to choose the most appropriate treatment for patients with heart failure associated with right ventricular dysfunction.